FAQs

There is no universal threshold, but the relevant question is whether the construction introduces interface interactions, tolerance accumulation, or process sequencing constraints that would not exist in a simpler construction. A two-layer construction with dissimilar materials and a tight finished tolerance can present the same design-for-manufacturability challenges as a five-layer construction with more forgiving specifications. Layer count is a proxy for complexity, not a definition of it.

Not typically. Adhesive failures originate during converting, which requires specialized process control and material expertise.

Some can perform limited converting, but most are not structured for complex multilayer, adhesive-based, or contamination-sensitive applications that require specialized process control.

Yes. Some suppliers maintain cleanrooms but only apply them to specific operations or products. Confirm that cleanroom conditions are integrated directly into the converting processes for your project—laminating, die cutting, slitting—and ask for documentation showing how those processes are controlled and monitored under cleanroom conditions.

The distinction requires lot traceability and process documentation. If a supplier can correlate yield data with specific material lots and specific process parameters, they can usually isolate the cause. If they cannot, both variables are suspect. A supplier without lot traceability cannot reliably distinguish material-driven from process-driven yield loss.

Process changes during scale-up — new tooling, higher volumes, different material lots — must go through change control under ISO 13485:2016. Components developed at an R&D or developmental level are not yet operating under a validated production process. Scaling up requires demonstrating that the production process consistently meets specification under real production conditions, which means validation steps are required before full production release — not just operational adjustments. This makes the transition to production-level manufacturing a defined quality event, not just an operational one.

Adhesive chemistry, coating weight, substrate thickness, and liner release force all vary naturally between lots. A process optimized for one lot may underperform with another. Production processes need to be qualified across the range of incoming material variation, not just against a single prototype lot.

Multilayer constructions are more sensitive to the prototype-to-production gap than single-layer components because tolerance stack-up only becomes a yield driver at volume, material lot variation affects multiple interfaces simultaneously, and process changes between prototype and production tooling (manual to automated laminating, for example) affect registration accuracy across the entire stack. Planning the transition before prototype tooling is committed is how these risks are managed rather than discovered.

Before adhesive selection is finalized and before production tooling is committed — ideally during the design phase when material stack and feature placement decisions are still open. The highest-value DFM input occurs when changes are still low-cost. After tooling is built, the cost of addressing convertibility issues increases significantly.

No. Most failures originate from process conditions, contamination, or material interaction—not the adhesive itself.

Yield expectations vary significantly by application complexity, material type, and tolerance requirements. More relevant than a benchmark rate is whether the supplier can demonstrate consistent yield within a defined range, identify causes when yield deviates, and show a track record of corrective action. Ask for yield data across multiple production runs, not just a single reference number.

Medical converting is the modification and assembly of various materials during the manufacturing of a medical product. Often, individual components are the output of a converting process, and those components are assembled to produce the finished product. There are a variety of medical converting processes, including laminating, die cutting, and slitting and rewinding. A wide range of materials are used in medical converting depending on the product’s specifications. Often, these materials are medical-grade, and the converting processes take place in a clean room.

Advantage Converting has provided medical converting services for more than 25 years. Medical converting applications include advanced wound care, medical devices and disposables, microfluidics, wearables, and flexible packaging.